Last Updated: November 20, 2026

Claims for Patent: 11,291,739

« Back to Dashboard


Summary for Patent: 11,291,739
Title:System and methods for sterilizing enclosed spaces using ozone
Abstract:Systems and methods for sterilizing an enclosed space using ozone are disclosed herein. Various embodiments of the devices and methods also provide for accelerated degradation of the ozone upon sterilization. The methods can include identifying enclosed spaces, sterilizing enclosed spaces through ozone generation, generating reports and transmitting the reports. The sterilization unit disclosed herein can sterilize a plurality of enclosed spaces, such as a fleet of medical response vehicles.
Inventor(s):Steven J. JURAK, Anthony M. SORGE, SR.
Assignee: Gene Therapy Systems
Application Number:US17/031,014

Details for Patent 11,291,739

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Glaxosmithkline Biologicals SHINGRIX zoster vaccine recombinant, adjuvanted Injection 125614 October 20, 2017 ⤷  Start Trial 2040-09-24
Glaxosmithkline Biologicals SHINGRIX zoster vaccine recombinant, adjuvanted For Injection 125614 July 23, 2021 ⤷  Start Trial 2040-09-24
Glaxosmithkline Biologicals SHINGRIX zoster vaccine recombinant, adjuvanted Injection 125614 July 16, 2025 ⤷  Start Trial 2040-09-24
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

International Patent Family for US Patent 11,291,739

Country Patent Number Estimated Expiration
United States of America 10786588 ⤷  Start Trial
United States of America 10980910 ⤷  Start Trial
United States of America 2014193296 ⤷  Start Trial
United States of America 2017072082 ⤷  Start Trial
United States of America 2017281823 ⤷  Start Trial
United States of America 2019030204 ⤷  Start Trial
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.